JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 49 filers reported holding JANUX THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $104,914,792 | 2.38% |
| EcoR1 Capital, LLC | 3,838,486 | $46,445,681 | 1.50% |
| Samsara BioCapital, LLC | 360,414 | $4,361,009 | 0.90% |
| BVF INC/IL | 1,585,677 | $19,186,692 | 0.70% |
| Orbimed Advisors | 2,836,386 | $34,320,271 | 0.67% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 900,000 | $10,890,000 | 0.02% |
| Woodline Partners LP | 137,300 | $1,661,330 | 0.02% |
| Vident Investment Advisory, LLC | 55,483 | $671,344 | 0.02% |
| JANUS HENDERSON GROUP PLC | 1,869,076 | $22,611,527 | 0.02% |
| FMR LLC | 10,281,288 | $124,403,584 | 0.01% |
| Citadel Advisors | 1,853,026 | $22,421,615 | 0.01% |
| AMERICAN INTERNATIONAL GROUP, INC. | 8,282 | $100,212 | 0.00% |
| METROPOLITAN LIFE INSURANCE CO/NY | 1,004 | $12,148 | 0.00% |
| Squarepoint Ops LLC | 13,167 | $159,321 | 0.00% |
| DekaBank Deutsche Girozentrale | 49,500 | $574 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,344 | $40 | 0.00% |
| MetLife Investment Management, LLC | 10,614 | $128,429 | 0.00% |
| TUCKER ASSET MANAGEMENT LLC | 250 | $3,025 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 354,585 | $4,290,478 | 0.00% |
| MORGAN STANLEY | 33,504 | $405,399 | 0.00% |
External links
This page lists JANUX THERAPEUTICS INC's shareholders in Q1 2023. To view JANUX THERAPEUTICS INC's shareholder history, click here.